Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

(2018) Frank Stephen Hodi et al.   LANCET ONCOLOGY

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

(2016) F Stephen Hodi et al.   LANCET ONCOLOGY

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

(2015) C. Gebhardt et al.   CLINICAL CANCER RESEARCH

Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma

(2015) Nikolaus B. Wagner et al.   INTERNATIONAL JOURNAL OF CANCER

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

(2015) Seth B. Coffelt et al.   NATURE

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells

(2014) P. Sinha et al.   JOURNAL OF IMMUNOLOGY

S-100B: A Stronger Prognostic Biomarker than LDH in Stage IIIB–C Melanoma

(2013) K. P. Wevers et al.   ANNALS OF SURGICAL ONCOLOGY

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

(2013) B. Weide et al.   CLINICAL CANCER RESEARCH

S100A9 Is a Novel Ligand of EMMPRIN That Promotes Melanoma Metastasis

(2012) T. Hibino et al.   CANCER RESEARCH

An Attempt at a Molecular Prediction of Metastasis in Patients with Primary Cutaneous Melanoma

(2012) Melanie Gschaider et al.   PLoS One

Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs

(2010) Arjun Saha et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse

(2009) Friederike Egberts et al.   MELANOMA RESEARCH

Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin

(2008) Joerg Wenzel et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694

(2008) Ahmad A. Tarhini et al.   JOURNAL OF CLINICAL ONCOLOGY

RAGE signaling sustains inflammation and promotes tumor development

(2008) Christoffer Gebhardt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

(2008) Pingyan Cheng et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Gene Expression Profiling of Lichen Planus Reflects CXCL9+-Mediated Inflammation and Distinguishes this Disease from Atopic Dermatitis and Psoriasis

(2007) Joerg Wenzel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY